These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18579854)

  • 61. Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach.
    Consonni S; Mainini V; Pizzardi A; Gianazza E; Chinello C; Locatelli A; Magni F
    Arch Gynecol Obstet; 2014 Feb; 289(2):299-306. PubMed ID: 23872981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aqueous two-phase partitioning for proteomic monitoring of cell surface biomarkers in human peripheral blood mononuclear cells.
    Everberg H; Peterson R; Rak S; Tjerneld F; Emanuelsson C
    J Proteome Res; 2006 May; 5(5):1168-75. PubMed ID: 16674106
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and characterization of proteins in amniotic fluid that are differentially expressed before and after antenatal corticosteroid administration.
    Lee J; Park JS; Norwitz ER; Kim BJ; Park CW; Jun JK; Syn HC
    Am J Obstet Gynecol; 2010 Apr; 202(4):388.e1-388.e10. PubMed ID: 20350648
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Artificial neural networks combined with surface-enhanced laser desorption/ionization mass spectra distinguish endometriosis from healthy population.
    Wang L; Zheng W; Yu JK; Jiang WZ; Mu L; Zhang SZ
    Fertil Steril; 2007 Dec; 88(6):1700-2. PubMed ID: 17482609
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proteomic analysis of amniotic fluid for the diagnosis of fetal aneuploidies.
    Kolialexi A; Tounta G; Mavrou A; Tsangaris GT
    Expert Rev Proteomics; 2011 Apr; 8(2):175-85. PubMed ID: 21501011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Using SELDI-TOF mass spectrometry on amniotic fluid and for clinical proteomics and theranostics in disorders of pregnancy.
    Buhimschi IA
    Methods Mol Biol; 2012; 818():171-97. PubMed ID: 22083824
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of relaxin's antifibrotic action by SELDI-TOF mass spectrometry-based profiling of relaxin knockout mice, a model of progressive fibrosis.
    Giannakis E; Macris M; Chan L; Tregear GW; Samuel CS; Wade JD
    Ann N Y Acad Sci; 2009 Apr; 1160():350-2. PubMed ID: 19416218
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form.
    Buhimschi IA; Buhimschi CS; Weiner CP; Kimura T; Hamar BD; Sfakianaki AK; Norwitz ER; Funai EF; Ratner E
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):837-44. PubMed ID: 16002632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of disease biomarkers by profiling of serum proteins using SELDI-TOF mass spectrometry.
    Langbein S
    Methods Mol Biol; 2008; 439():191-7. PubMed ID: 18370104
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects.
    Canter MP; Graham CA; Heit MH; Blackwell LS; Wilkey DW; Klein JB; Merchant ML
    Am J Obstet Gynecol; 2008 May; 198(5):553.e1-6. PubMed ID: 18455532
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proteomic analysis of suction blister fluid isolated from human skin.
    Macdonald N; Cumberbatch M; Singh M; Moggs JG; Orphanides G; Dearman RJ; Griffiths CE; Kimber I
    Clin Exp Dermatol; 2006 May; 31(3):445-8. PubMed ID: 16681597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.
    Hsu TY; Lin H; Hung HN; Yang KD; Ou CY; Tsai CC; Cheng HH; Chung SH; Cheng BH; Wong YH; Chou AK; Hsiao CC
    PLoS One; 2016; 11(1):e0145908. PubMed ID: 26752631
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis.
    Ueda K; Nakanishi T; Shimizu A; Takubo T; Matsuura N
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):65-9. PubMed ID: 18275676
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mass spectrometry-based proteomics for pre-eclampsia and preterm birth.
    Law KP; Han TL; Tong C; Baker PN
    Int J Mol Sci; 2015 May; 16(5):10952-85. PubMed ID: 26006232
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum biomarkers of vascular cognitive impairment evaluated by bead-based proteomic technology.
    Xi L; Junjian Z; Yumin L; Yunwen L; Hongbin W
    Neurosci Lett; 2009 Sep; 463(1):6-11. PubMed ID: 19631719
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proteomic identification and profiling of canine lymphoma patients.
    Ratcliffe L; Mian S; Slater K; King H; Napolitano M; Aucoin D; Mobasheri A
    Vet Comp Oncol; 2009 Jun; 7(2):92-105. PubMed ID: 19453363
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.